Viewing Study NCT04944368


Ignite Creation Date: 2025-12-24 @ 5:26 PM
Ignite Modification Date: 2026-01-01 @ 7:01 AM
Study NCT ID: NCT04944368
Status: COMPLETED
Last Update Posted: 2022-10-13
First Post: 2021-06-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)
Sponsor: Cinnagen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: VAC.CIN.PT.II
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View